Gyeonggi-do, South Korea

Dae-Gyu Park



Average Co-Inventor Count = 9.0

ph-index = 2

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2021-2025

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Dae-Gyu Park: Innovator in Aminopyrimidine Derivatives

Introduction

Dae-Gyu Park is a prominent inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of aminopyrimidine derivatives. With a total of 4 patents to his name, Park's work has the potential to impact the treatment of various diseases.

Latest Patents

One of his latest patents is focused on an improved process for preparing aminopyrimidine derivatives or pharmaceutically acceptable salts. This invention specifically targets selective inhibitory activity against protein kinases, especially those associated with mutant epidermal growth factor receptors. Additionally, the patent provides novel intermediates that are useful for this process and outlines methods for preparing these intermediates.

Career Highlights

Dae-Gyu Park is currently associated with Yuhan Corporation, a leading pharmaceutical company in South Korea. His work at Yuhan Corporation has allowed him to further his research and development efforts in the pharmaceutical sector.

Collaborations

Some of his notable coworkers include Sang-Ho Oh and Ja-Heouk Khoo, who have collaborated with him on various projects within the company.

Conclusion

Dae-Gyu Park's innovative work in the field of aminopyrimidine derivatives showcases his commitment to advancing pharmaceutical science. His contributions are poised to make a significant impact on the treatment of diseases related to protein kinases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…